Asma Dilawari
United States Food and Drug Administration
ORCID: 0000-0001-5706-9138Also affiliated with Center for Drug Evaluation and Research
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 8 papers. Top paper: “FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer”.
Mirat Shah, Gwynn Ison, Haley Gittleman, Mallorie H. Fiero, Ankit Shah +20 more
James Buturla, Christy Osgood, Xin Gao, Wei Chen, Tiffany K. Ricks +14 more
Kelly E. Rentscher, Wanting Zhai, X. Zhou, T. A. Ahles, J. Ahn +16 more
Xingtao Zhou, Jaeil Ahn, Brent J. Small, Wanting Zhai, Traci N. Bethea +17 more
Xingtao Zhou, Brent J. Small, Harvey Jay Cohen, Asma Dilawari, Sunita K. Patel +14 more
Xingtao Zhou, Jaeil Ahn, Brent J. Small, Wanting Zhai, Traci N. Bethea +17 more
Jaeil Ahn, Xingtao Zhou, Wanting Zhai, Tim A. Ahles, Traci N. Bethea +15 more
Kelly E. Rentscher, Wanting Zhai, Tim A. Ahles, Jaeil Ahn, Traci N. Bethea +14 more